Titan Pharmaceuticals

$2.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-4.78%) As of 6:15 PM UTC today

Why Robinhood?

You can buy or sell TTNP and other stocks, options, and ETFs commission-free!

About TTNP

Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.

CEO
Sunil Bhonsle, MBA
Employees
12
Headquarters
South San Francisco, California
Founded
1992
Market Cap
25.10M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
348.79K
High Today
$2.75
Low Today
$2.55
Open Price
$2.74
Volume
414.05K
52 Week High
$14.06
52 Week Low
$2.55

TTNP Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Mar 31, After Hours

You May Also Like

ALTA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure